Mi Sun Ahn

1.8k total citations
48 papers, 840 citations indexed

About

Mi Sun Ahn is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mi Sun Ahn has authored 48 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Mi Sun Ahn's work include Lung Cancer Treatments and Mutations (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Metastasis and carcinoma case studies (7 papers). Mi Sun Ahn is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Metastasis and carcinoma case studies (7 papers). Mi Sun Ahn collaborates with scholars based in South Korea, United States and Ethiopia. Mi Sun Ahn's co-authors include Young Wha Koh, Seung Hyup Hyun, Su Jin Lee, Hyun Woo Lee, Seok Yun Kang, Jin‐Hyuk Choi, Yong Won Choi, Eun Joo Kang, Keon Uk Park and Yoon Hee Choi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Mi Sun Ahn

44 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mi Sun Ahn South Korea	13	524	466	188	144	107	48	840
Angela Takano Singapore	16	425 0.8×	376 0.8×	230 1.2×	97 0.7×	97 0.9×	51	906
Zhendong Chen China	17	357 0.7×	521 1.1×	102 0.5×	194 1.3×	153 1.4×	54	1.0k
Quchang Ouyang China	15	476 0.9×	718 1.5×	178 0.9×	181 1.3×	88 0.8×	80	1.0k
Arsela Prelaj Italy	18	521 1.0×	677 1.5×	169 0.9×	116 0.8×	59 0.6×	82	1.0k
Anastasios Dimou United States	16	311 0.6×	481 1.0×	201 1.1×	71 0.5×	67 0.6×	67	800
Prantesh Jain United States	14	255 0.5×	382 0.8×	107 0.6×	187 1.3×	55 0.5×	46	626
Shan Xiong China	15	350 0.7×	464 1.0×	148 0.8×	82 0.6×	94 0.9×	49	778
Sophie Marguet France	8	402 0.8×	395 0.8×	86 0.5×	123 0.9×	184 1.7×	12	806
Niamh Coleman United States	14	256 0.5×	281 0.6×	204 1.1×	110 0.8×	39 0.4×	41	662
Shikai Wu China	18	284 0.5×	461 1.0×	159 0.8×	85 0.6×	58 0.5×	73	796

Countries citing papers authored by Mi Sun Ahn

Since Specialization

Citations

This map shows the geographic impact of Mi Sun Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Sun Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Sun Ahn more than expected).

Fields of papers citing papers by Mi Sun Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Sun Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Sun Ahn. The network helps show where Mi Sun Ahn may publish in the future.

Co-authorship network of co-authors of Mi Sun Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Sun Ahn. A scholar is included among the top collaborators of Mi Sun Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Sun Ahn. Mi Sun Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahn, Mi Sun, Jiyeong Jeong, Eun Hui Lee, et al.. (2025). Systemic inflammation-induced adipose tissue remodeling drives psoriasis exacerbation in obesity through epigenetic and immunometabolic dysregulation. Theranostics. 15(16). 8639–8657. 2 indexed citations

Kim, Tae‐Hwan, Jin‐Hyuk Choi, Mi Sun Ahn, et al.. (2024). Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study. BMC Cancer. 24(1). 70–70. 2 indexed citations

Chae, Heejung, Harim Koo, Sun Young Kim, et al.. (2024). Genomic landscape and therapeutic implications in advanced solid cancers: KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors, KCSG AL-22-09).. Journal of Clinical Oncology. 42(16_suppl). 11161–11161.

Kim, Yu Jung, Koung Jin Suh, Se Hyun Kim, et al.. (2024). Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second‐line treatment (EAGLES, Korean Cancer Study Group UN18‐06). Cancer. 131(1). e35609–e35609. 2 indexed citations

Kim, Yongsoo, Minkwan Kim, Yoon Jun Kim, et al.. (2023). 1930P phase II trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (KCSG UN18-06). Annals of Oncology. 34. S1037–S1038. 1 indexed citations

Lee, Kyoungmin, Jong Won Lee, Jungmin Choi, et al.. (2023). Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer. Scientific Reports. 13(1). 9928–9928. 6 indexed citations

Choi, Yong Won, Tae‐Hwan Kim, Mi Sun Ahn, et al.. (2023). Differential efficacy of tyrosine kinase inhibitors (TKIs) according to the types of EGFR mutations and agents in non-small cell lung cancer (NSCLC): A real-world study.. Journal of Clinical Oncology. 41(16_suppl). e21040–e21040. 1 indexed citations

Choi, Jin‐Hyuk, Seok Yun Kang, Hyun Woo Lee, et al.. (2022). Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin. The Korean Journal of Internal Medicine. 37(3). 653–659. 2 indexed citations

Kim, Tae‐Hwan, Yong Won Choi, Hyun Woo Lee, et al.. (2021). Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data. BMC Cancer. 21(1). 325–325. 7 indexed citations

10.

Yang, Kyungmi, et al.. (2021). Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning. BMC Cancer. 21(1). 741–741. 2 indexed citations

11.

Kim, Miso, Bhumsuk Keam, Chan‐Young Ock, et al.. (2020). Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07. Thoracic Cancer. 11(12). 3482–3489. 19 indexed citations

12.

Choi, Yong Won, Mi Sun Ahn, Hyun Woo Lee, et al.. (2018). The role of third-line chemotherapy in recurrent or metastatic gastric cancer. Medicine. 97(39). e12588–e12588. 5 indexed citations

13.

Choi, Yong Won, Mi Sun Ahn, Hyun Woo Lee, Seok Yun Kang, & JH Choi. (2017). Is surgical resection beneficial in recurrent or metastatic gastric cancer?. Annals of Oncology. 28. v222–v223. 5 indexed citations

14.

Choi, Yong Won, Seong Hyun Jeong, Mi Sun Ahn, et al.. (2015). Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation. Journal of Korean Medical Science. 30(10). 1416–1416. 6 indexed citations

15.

Choi, Yong Won, Mi Sun Ahn, Jin‐Hyuk Choi, et al.. (2015). High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy. International Journal of Hematology. 103(2). 210–218. 6 indexed citations

16.

Lee, Hyun Woo, O Kyu Noh, Young‐Taek Oh, et al.. (2015). Radiation Therapy–First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 94(3). 621–627. 16 indexed citations

17.

Choi, Yong Won, Seong Hyun Jeong, Mi Sun Ahn, et al.. (2014). Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP. Journal of Korean Medical Science. 29(11). 1493–1493. 19 indexed citations

18.

Kang, Seok Yun, Jae Ho Han, Mi Sun Ahn, et al.. (2011). Helicobacter pyloriinfection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. International Journal of Cancer. 130(4). 948–958. 40 indexed citations

19.

Jeong, Seong Hyun, Hyun Woo Lee, Seok Yun Kang, et al.. (2009). Clinical Significance of Co-expression of Aberrant Antigens in Acute Leukemia. The Korean Journal of Hematology. 44(2). 67–67. 1 indexed citations

20.

Jung, Hyun Joo, Jae Eun Yu, Ki Soo Pai, et al.. (2005). Giant Neonatal Hemangioendothelioma of the Liver Diagnosed by 99mTc-RBC Scintigraphy.. Journal of the Korean Society of Neonatology. 12(1). 105–111.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact